Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Downregulation of DUSP9 promotes tumor progression and contributes to poor prognosis in human colorectal cancer

PROVIDER: PRJNA659790 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12536108.fastq.gz	Fastqsanger.gz
	SRR12536109.fastq.gz	Fastqsanger.gz
	SRR12536110.fastq.gz	Fastqsanger.gz
	SRR12536111.fastq.gz	Fastqsanger.gz
	SRR12536112.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

E-GEOD-43730

Project description:A Myc transcriptional program that is independent of EMT drives a poor prognosis tumor-propagating phenotype in HER2+ breast cancer

2025-01-24 | E-GEOD-43730 | ExpressionAtlas

Homo sapiens

Project description:A five-gene signature is associated with tumor progression and poor prognosis in colorectal cancer

| PRJNA117645 | ENA

E-GEOD-95132

Project description:RNA-seq of colorectal cancer primary tumor and adjacent colon tissue

2019-05-14 | E-GEOD-95132 | ExpressionAtlas

E-PROT-138

Project description:Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

2024-06-05 | E-PROT-138 | ExpressionAtlas

BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins

Project description:Colorectal cancer (CRC) is the third most commonly diagnosed cancer, which despite recent advances in treatment, remains incurable due to molecular heterogeneity of tumor cells. The B-cell lymphoma 9 (BCL9) oncogene functions as a transcriptional co-activator of the Wnt/β-catenin pathway, which plays critical roles in CRC pathogenesis. Here we have identified a β-catenin-independent function of BCL9 in a poor-prognosis subtype of CRC tumors characterized by expression of stromal and neural associated genes. In response to spontaneous calcium transients or cellular stress, BCL9 is recruited adjacent to the interchromosomal regions, where it stabilizes the mRNA of calcium signaling and neural associated genes by interacting with paraspeckle proteins. BCL9 subsequently promotes tumor progression and remodeling of the tumor microenvironment (TME) by sustaining the calcium transients and neurotransmitter-dependent communication among CRC cells. These data provide additional insights into the role of BCL9 in tumor pathogenesis and point towards additional avenues for therapeutic intervention.

2020-05-27 | PXD016172 | Pride

HIGHLY EXPRESSED GENES IN RAPIDLY PROLIFERATING TUMOR CELLS AS NEW TARGETS FOR COLORECTAL CANCER TREATMENT

Project description:The clinical management of colorectal cancer patients has significantly improved due to the identification of new chemotherapeutic targets. Since rapid tumor proliferation is associated with poor patient prognosis, here we characterize the transcriptional signature of rapidly proliferating colorectal cancer cells in an attempt to identify novel candidate therapeutic targets. Therefore, the doubling time of 52 colorectal cancer cell lines was determined and genome-wide expression profiling of a subset of 31 of these cell lines was assessed by microarray analysis.

2015-05-13 | E-MTAB-2971 | biostudies-arrayexpress

Next generation sequencing facilities quantitative analysis of SHARPIN knockout or non-target LoVo cells

Project description:Colorectal cancer (CRC) is one of the most common cancers and a major cause of cancer mortality worldwide. Further improvements are needed for the treatment of CRC. The E3 ubiquitin ligase is an enzyme that plays an important role in regulating protein expression levels via posttranslational ubiquitin-mediated proteolysis, and it is reportedly involved in the progression of various cancers, making it a target of recent interest in anticancer therapy. In this study, using comprehensive expression analysis involving spatial transcriptomic analysis with single-cell RNA sequencing in clinical CRC datasets, we identified the ubiquitin-associated protein Shank-associated RH domain interactor (SHARPIN) as a putative driver gene located on amplified chromosome 8q. SHARPIN was overexpressed in tumor cells, and high expression of SHARPIN in tumor tissues was positively correlated with lymphatic invasion and was independently predictive of a poor prognosis in CRC patients. In vitro and in vivo analyses using SHARPIN-overexpressing or -knockout CRC cells revealed that SHARPIN upregulated MDM2, resulting in subsequent downregulation of p53, which inhibits tumor cell apoptosis and promotes tumor growth in CRC. Furthermore, SHARPIN overexpression and significant effects on survival were observed in various cancers. In conclusion, SHARPIN is a novel driver gene that potentially promotes tumor growth following apoptosis inhibition in part by inhibiting p53 expression via MDM2 upregulation; therefore, SHARPIN represents a potential therapeutic target for CRC.

2024-02-14 | GSE255286 | GEO

E-PROT-18

Project description:Colorectal cancer cell line proteomes

2021-05-25 | E-PROT-18 | ExpressionAtlas

E-PROT-101

Project description:Biomarkers discovery for Colorectal cancer

2023-06-21 | E-PROT-101 | ExpressionAtlas

Homo sapiens

Project description:COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

| PRJNA188671 | ENA